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I

njections for vaccinations, the most common source of
iatrogenic pain in childhood,1 are administered at multiple times to almost all Canadian children throughout
infancy, childhood and adolescence.2 The pain associated
with such injections is a source of distress for children, their
parents and those administering the injections. If not
addressed, this pain can lead to preprocedural anxiety in the
future, fear of needles and nonadherence with vaccination
schedules.3 It is estimated that up to 25% of adults have a
fear of needles,4 with most fears developing in childhood.5
About 10% of the population avoids vaccination and other
needle procedures because of needle fears.3
Conversely, minimizing pain during childhood vaccination can help to prevent distress, development of needle fears
and subsequent health care avoidance behaviours such as
nonadherence with vaccination schedules. More positive
experiences during vaccine injections also maintain and promote trust in health care providers.3
In light of the prevalence of pain during vaccine injections
and the potential for substantial adverse sequelae, we identified a need for a national guidance document to address this
important public health issue. Although the topic was covered
in a previous narrative review1 and a national guideline,4 neither of those documents was based on the requisite systematic
approach and rigorous guideline development process. Moreover, additional data have been published since the appearance of the previous documents.
Our objective was to develop a clinical practice guideline,
based on systematic reviews of the literature, as interpreted
by experts, to assist clinicians in managing procedure-related
pain and distress among children undergoing vaccine injections. The scope was limited to acute (immediate) pain and
distress at the time of vaccine injection in children 0 to 18
years of age. We did not consider the management of
delayed-onset pain occurring in the hours or days after the
injection. The term “distress” is often used to refer to the
combination of pain and anxiety or fear experienced by children before and during painful medical procedures. For the
purposes of this guideline, we considered distress and pain
together, referring to the combination as “pain.”

Key points
•

Vaccine injections performed in childhood are a
substantial source of distress.

•

Untreated pain can have long-term consequences,
including preprocedural anxiety, hyperalgesia, needle
fears and avoidance of health care.

•

Simple, cost-effective, evidence-based pain-relieving
strategies are available.

•

A “3-P” approach, combining pharmacologic, physical and
psychological factors, improves pain relief.

Methods
We convened an interdisciplinary expert panel, the Help
ELiminate Pain in KIDS (HELPinKIDS) Team, to develop
the guideline. Individual panel members, with the required
expertise in areas of vaccination and immunization, pediatrics, pain, evidence-based medicine, education, knowledge
translation, health policy and guideline development, were
Faculty of Pharmacy (Taddio) and Departments of Paediatrics (Ipp), of Family
and Community Medicine (Midmer) and of Health Policy, Management and
Evaluation (Palda, Shah), Faculty of Medicine, University of Toronto, Toronto,
Ont.; Research Institute (Taddio, Ipp, Pillai Riddell) and Department of Psychiatry (Pillai Riddell), The Hospital for Sick Children, Toronto, Ont.; Canadian
Center for Vaccinology (Appleton, Halperin, MacDonald, Scott), Halifax, NS;
Departments of Pediatrics (Bortolussi, Halperin, MacDonald, Scott) and of
Psychology (Chambers), IWK Health Centre, Halifax, NS; Infectious Diseases and
Immunization Committee (Bortolussi) and Drug Therapy and Hazardous Products Committee (Rieder), Canadian Paediatric Society; Departments of Microbiology and Immunology (Bortolussi, Halperin), of Pediatrics (MacDonald) and
of Emergency Medicine (Scott), Faculty of Medicine, and Department of Pediatrics/Psychology (Chambers), Faculty of Science, Dalhousie University, Halifax,
NS; Toronto Public Health (Dubey), Toronto, Ont.; Capital Health Region (Hanrahan), Edmonton, Alta.; National Advisory Committee on Immunization (Hanrahan); private practice (Lockett), Milton, Ont.; Healthy Child Development
Program (Mousmanis), Ontario College of Family Physicians, Toronto, Ont.;
Department of Medicine (Palda), St. Michael’s Hospital, Toronto, Ont.; British
Columbia Centre for Disease Control (Pielak), Vancouver, BC; Department of
Psychology (Pillai Riddell), York University, Toronto, Ont.; Children’s Hospital of
Western Ontario (Rieder), London, Ont.; Department of Medicine (Rieder),
University of Western Ontario, London, Ont.; Department of Paediatrics
(Shah), Mount Sinai Hospital, Toronto, Ont.
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selected from across Canada to represent different perspectives and experiences.
The guideline development process was based on published
methods.6 Details of the methods can be found in the full guideline (see Appendix 1, available at www.cmaj.ca/cgi/content/full
/cmaj.092048/DC1). Briefly, we used published literature,7,8
interviews with key informants and discussions with panel
members and stakeholder partners,8 including parents,8,9 to identify 32 clinical questions for consideration in the guideline. We
subsequently reduced the number of clinical questions to 18, to
reflect the evidence base, as described below.
Pain management is usually based on a “3-P” approach
involving pharmacologic, physical and psychological strategies. Therefore, our evidence base encompassed all of these
domains. For the purposes of this guideline, selected panel
members performed three systematic reviews and meta-analyses, one for each of the three domains of pain management.10−12 We limited the evidence to randomized controlled
trials and studies with quasi-experimental designs. We used
the Cochrane Risk of Bias Tool to determine the quality of
included studies. We critically appraised the evidence and
generated recommendations using the evidence-based methods outlined by the Canadian Task Force on Preventive
Health Care,13 including an accompanying level of evidence
and grade for each recommendation (Table 1).14
In total, we evaluated 71 studies that included 8050 chil-

dren. We formulated a recommendation for each clinical question according to the strength of the scientific evidence (i.e.,
study design and methodologic quality), with consideration of
the values that expert reviewers attributed to various outcomes
and parents’ preferences. We used a consensus process to
arrive at the final wording for each recommendation.
We circulated the guideline to relevant experts, some of
whom represented stakeholder organizations, for external
review according to the AGREE instrument (Appraisal of
Guidelines for Research and Evaluation; www.agreetrust
.org). In addition, three trained members of the Guidelines
Advisory Committee (www.gacguidelines.ca) who were not
involved in the guideline development process independently
evaluated the guideline. We discussed the comments of all
reviewers and incorporated them into the final manuscript, as
appropriate. We then finalized and approved the guideline.
Funding for this project was provided by the Canadian
Institutes of Health Research. The funding agency had no role
in developing the recommendations, and its views and interests did not influence the recommendations.

Clinical recommendations

For 14 of the 18 questions, there was sufficient evidence to
make a practice recommendation to reduce pain (Table 2).
These recommendations have been organized into five clusters: infants, injection procedure, parentled strategies, pharmacotherapy and
Table 1: Criteria for evaluating evidence and grading recommendations*
psychological strategies. For the remaining four clinical questions, there was
Level or grade
Criteria
insufficient evidence to make a practice
Evidence
recommendation (Table 3).
I
Evidence from randomized controlled trial(s)
Several of the practice recommendaII-1
Evidence from controlled trial(s) without
tions relating to the injection procedure
randomization
can be implemented immediately by
II-2
Evidence from cohort or case–control analytic studies,
health care providers in all vaccination
preferably from more than one centre or research
practice settings, as they do not require
group
planning or additional resources (e.g,
II-3
Evidence from comparisons between times or places
time, supplies or money). Examples of
with or without the intervention; dramatic results in
these easily adopted pain-relieving
uncontrolled experiments could be included here
strategies include performing intramusIII
Opinions of respected authorities, based on clinical
cular injections rapidly without prior
experience; descriptive studies or reports of expert
aspiration, positioning children upright,
committees
injecting the most painful vaccine last
Recommendation
when multiple vaccines are being adminA
There is good evidence to recommend the action.
istered and providing tactile stimulation.
B
There is fair evidence to recommend the action.
Performing intramuscular injections
C
The existing evidence is conflicting and does not
rapidly
without prior aspiration probably
allow making a recommendation for or against the
reduces pain through the combined
use of the action; however, other factors may
effects of shortening the time of contact
influence decision-making.
between needle and tissue and reducing
D
There is fair evidence to recommend against the
action.
lateral movement of the needle (“wiggle”)
within the tissue. The long-standing
E
There is good evidence to recommend against the
action.
practice of aspiration was initially proposed to reduce the risk of intravascular
I
There is insufficient evidence (in quantit y or quality
or both) to make a recommendation; however, other
injection of the vaccine. However, the
factors may influence decision-making.
sites commonly used for vaccine injections are devoid of large blood vessels,
*Adapted, with permission, from Palda and colleagues.
14
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Table 2: Recommendations to reduce pain during vaccine injections in children* (part 1 of 2)

Clinical question

Recommendation

Level of
Grade of
evidence† recommendation†

Infants
Among infants undergoing vaccination,
does breastfeeding during the procedure
reduce pain at the time of injection?

To reduce pain at the time of injection,
encourage breastfeeding mothers to
breastfeed their infants during
vaccination

I

A

Among infants undergoing vaccination,
does administration of sweet-tasting
solutions reduce pain at the time of
injection?

To reduce pain at the time of injection
among infants up to 12 months of age
who cannot be breastfed during
vaccination, administer a sweet-tasting
solution during vaccination

I

A

Among children undergoing vaccination,
does administering one commercial brand
of a vaccine rather than another
commercial brand of the same vaccine
cause less pain at the time of injection?

If more than one commercial brand of a
vaccine is available, and the brands are
interchangeable, inject the least painful
brand during vaccination of children, to
reduce pain at the time of injection

I

A

Among children undergoing vaccination,
does positioning the child in a supine
position result in more pain at the time
of injection?

To reduce pain at the time of injection,
do not place children in a supine
position during vaccination

I

E

Among children undergoing
intramuscular injection of vaccine, should
slow injection with aspiration be avoided
to reduce pain at the time of injection?

To reduce pain at the time of
injection, administer intramuscular
vaccines to children using a rapid
injection technique without aspiration

I

B

Among children receiving multiple
vaccine injections at a single vaccination
visit, does injecting the most painful
vaccine last decrease pain at the time of
injection?

When administering multiple vaccine
injections to children sequentially, inject
the most painful vaccine last to reduce
pain at the time of injection

I

B

Among children undergoing vaccination,
does rubbing the skin near the injection
site before and during the procedure
result in less pain at the time of
injection?

To reduce pain at the time of injection
among children aged ≥ 4 years, offer to
rub or stroke the skin near the injection
site with moderate intensity before and
during vaccination

II-1

B

Although there is insufficient evidence
for or against the use of parent-led
distraction or parent coaching during
vaccination of children as a way to
reduce pain at the time of injection,
clinicians may offer this intervention to
parents to reduce pain-related distress

I

B

To reduce pain at the time of injection,
encourage parents to use topical
anesthetics during vaccination of
children

I

A

Among children undergoing vaccination,
does use of clinician-led distraction result
in less pain at the time of injection?

To reduce pain at the time of injection,
use clinician-led distraction techniques
during vaccination of children

I

B

Among children undergoing vaccination,
does use of child-led distraction result in
less pain at the time of injection?

To reduce pain at the time of injection
among children aged ≥ 3 years, use childled distraction techniques during
vaccination

I

B

Injection procedure

Parent-led interventions
Among children undergoing vaccination,
does use of (1) parent-led distraction or
(2) parent coaching result in less pain and
pain-related distress at the time of
injection?

Pharmacotherapy
Among children receiving intramuscular
and subcutaneous injection of vaccines,
does application of topical anesthetics on
the skin before the injection reduce pain
at the time of injection?
Psychological interventions

CMAJ • DECEMBER 14, 2010 • 182(18)
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Table 2: Recommendations to reduce pain during vaccine injections in children* (part 2 of 2)

Clinical question

Recommendation

Grade of
Level of
evidence† recommendation†

Among children undergoing vaccination,
does slow, deep breathing or blowing
performed by the child result in less pain
at the time of injection?

To reduce pain at the time of injection,
have children aged ≥ 3 years engage in
slow, deep breathing or blowing during
vaccinations

I

B

Among children undergoing vaccination,
does use of combined psychological
interventions (i.e., interventions that
include at least one cognitive and one
behavioural intervention) result in less
pain and distress at the time of injection?

To reduce pain at the time of injection
among children aged ≥ 3 years, use
combined psychological interventions
during vaccination

I

B

Among children undergoing vaccination,
does suggesting that “it won’t hurt”
result in less pain at the time of injection?

Do not tell children that “it won’t hurt,”
as this type of statement, when used
alone, has been shown to be ineffective
in reducing pain at the time of injection

I

D

*There is some evidence that combining strategies improves pain relief.
†Levels of evidence and grades of recommendation are defined in Table 1.

and aspiration is no longer regarded as necessary. About onethird of vaccinators do not perform aspiration, and there have
been no documented harms caused by omitting this step.
Positioning children upright or holding them during vaccine
injections, rather than laying them supine, reduces pain. Children can be seated or held by a parent in a position that is most
comfortable for them (e.g., held in a bear hug or on the parent’s
lap). Although the exact mechanism underlying the reduction in
pain associated with this positioning is unknown, it may involve
a reduction in anxiety, which in turn reduces the perception of
pain. Conversely, excessive restraint may increase the child’s
distress, so parents and health care providers are encouraged to
hold and support children without using excessive force.
Children routinely receive two or more vaccine injections
during the same visit. Administering the most painful vaccine
last minimizes the priming effect of the first injection on subsequent injections, thus reducing overall pain. There is limited
research, however, regarding the optimal order of injection for
vaccines that are coupled for administration at the same visit. At
present, the two vaccines known to be relatively more painful
are M-M-R-II (Merck) and Prevnar (Wyeth). When these are
coupled with other vaccines, they should be given last.
Providing tactile stimulation by rubbing or stroking the skin
near the injection site before and during vaccine injections
reduces pain in children aged four years and older. The proposed mechanism involves blocking the transmission of the
pain sensation to the brain by means of competing touch sensation. This technique is often referred to as generating “white
noise.” The optimal method for rubbing (in terms of frequency,
intensity and pattern) is unknown. It should be tailored to the
request and comfort level of the individual child.
A few practice recommendations in this guideline, such as
breastfeeding or administration of sugar water (for infants)
and application of topical anesthetics and psychological interventions (for children of all ages), require some planning or
additional resources, or both, on the part of health care
providers and children and their families. Health care
1992

providers are encouraged to discuss these additional options
with parents and children (as appropriate) and to select the
strategies best suited to individual children.
Breastfeeding is considered a combined analgesic intervention because several aspects of breastfeeding (e.g., holding the
child, skin-to-skin contact, the sweet-tasting milk and the act
of sucking) attenuate pain responses. An adequate latch must
be established before the injection. This may take about one
minute. If an adequate latch cannot be established before the
injection or the infant is not being breastfed, sugar water can
be administered instead. The mechanism of action of sugar
water, although not fully elucidated, may involve release of
endogenous opioids through activation of sweet taste receptors
and distraction. Sugar water is easily prepared by mixing a
packet of sugar with 10 mL (two teaspoons) of water and feeding some to the infant a minute or two before the injection.
The infant should be monitored for minor adverse events such
as choking or gagging.
Topical anesthetics block the transmission of pain signals
from peripheral nociceptors. They are effective for vaccines
that are administered intramuscularly and subcutaneously. At
present, limited evidence indicates that these agents do not
interfere with the immunogenicity of the vaccine. Topical anesthetics are available for purchase without a prescription, and
parents have indicated a willingness to pay for them to mitigate
the pain associated with vaccine injection in their children.
However, parents require education about the use of these
agents, including the exact site or sites of administration, the
duration of application and possible adverse effects. Topical
anesthetics must be applied ahead of time, about 20–60 minutes before the injection, depending on the commercial product
being applied. The topical anesthetic can be applied upon
arrival at the clinic or school (by a parent or a qualified health
care professional or delegate) or before departure from home. If
multiple vaccines are being injected during the same visit, the
topical anesthetic can be applied at two separate sites (e.g.,
right and left legs). The vaccine or vaccines must be injected
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where the anesthetic has been applied. Health care providers
can use a nontoxic marker to outline the area of application.
The cost per dose is $5–$10. Transient changes in skin colour
are common. Systemic toxicity is rare but can occur if the dose
or the duration of application is excessive.
Distraction is a psychological intervention that involves
directing the child’s attention away from the procedure. Distraction led by a health care provider is effective for children of all
ages. For children three years of age and older, self-led distraction is also effective. Distraction led by a parent is less effective,
possibly because the parent has difficulty providing distraction
when he or she is also distressed. The panel recommends, however, that clinicians discuss parent-led interventions, including
distraction and coaching, on the grounds that some benefits have
been observed in terms of general pain-related distress. In addition, parents may benefit from a formal role, and there may be
limited availability of other individuals to deliver such interventions. It is important to ensure that age-appropriate distraction
strategies are used and that children are engaged with them.
When appropriate, involve the child in planning which distraction strategy will be used and in directing the distraction strategy. Examples of distraction strategies include toys (for infants),
bubbles (for toddlers), video games (for school-age children)
and music (for adolescents).
Deep (tummy) breathing is another effective psychological
intervention that can be used for children three years of age

and older. Deep breathing can be facilitated by having the
child blow bubbles or spin pinwheels with the breath. These
aids also act as distraction strategies.
Pain relief is enhanced when individual pain-relieving
strategies are combined. Therefore, health care providers are
encouraged to use a mix of strategies to mitigate pain. Parents
can be enlisted to help combine and coordinate many of these
strategies. In particular, parents can prepare their children,
apply topical anesthetics, bring a distraction aid to the appointment, coach the child during deep breathing and hold the child.
Additional details of the practice recommendations, including evidence summaries, references and clinical considerations, can be found in the full guideline (www.cmaj.ca/cgi
/doi/10.1503/cmaj.101720).

Implementation of the guideline
The information contained in this guideline is generalizable to
healthy children undergoing injection of vaccines worldwide.
We offer the following suggestions to assist in implementing
the guideline in various settings.
Context and facilitation
Organizations and health care providers involved in immunization are encouraged to adopt pain management as an integral component of the vaccination process. Supports should

Table 3: Interventions without sufficient evidence to make a recommendation regarding their use to reduce pain
during vaccine injections in children

Clinical question

Recommendation

Level of
evidence*

Grade of
recommendation*

Injection procedure
Among children undergoing vaccination,
does (1) application of a vapocoolant
spray or (2) application of ice or a
cool/cold pack on the skin before injection
of vaccine reduce pain at the time of
injection?

For children undergoing vaccination,
there is insufficient evidence for or
against the use of skin-cooling
techniques (vapocoolants, ice,
cool/cold packs) to reduce pain at the
time of injection

I

I

Among children undergoing vaccination,
does simultaneous injection by two
vaccination providers cause less pain at
the time of injection than sequential
injections by the same provider?

For children undergoing vaccination,
there is insufficient evidence for or
against the use of simultaneous
injections rather than sequential
injections to reduce pain at the time
of injection

I

I

For children undergoing vaccination,
there is insufficient evidence to
recommend for or against the use of a
specific route of administration for
vaccines that can be administered
intramuscularly or subcutaneously to
reduce pain at the time of injection

I

I

For children undergoing vaccination,
there is currently no demonstrated
benefit of administering acetaminophen or ibuprofen to reduce pain
at the time of injection

III

I

Route of administration
Among children undergoing vaccination,
for vaccines that can be administered
intramuscularly or subcutaneously, does
administering the vaccines intramuscularly,
rather than subcutaneously, cause less pain
at the time of injection?
Pharmacotherapy
Among children undergoing vaccination,
does administration of acetaminophen or
ibuprofen before the injection reduce pain
at the time of injection?

*Levels of evidence and grades of recommendation are defined in Table 1.
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be put in place to facilitate the implementation of these recommendations by health care providers.
Required resources
Some costs may be incurred by the incorporation of these recommendations into practice, because of required training of staff,
required time to practise pain management and expenditures to
acquire aids (e.g., bubbles) and resources (e.g., pamphlets for
parents and children). For the most part, these costs are relatively
modest and may be offset by shorter duration of the procedure
(because the child’s distress and struggling are lessened) and
faster recovery time. Many of the practice recommendations are
cost-neutral to parents and the health care system (e.g., rapid
intramuscular injection without aspiration).
Setting for vaccinations
Most of these practice recommendations can be incorporated
in many settings without adding any time to the vaccination
process (e.g., holding infants, tactile stimulation). Pain-relieving strategies that require additional time (e.g., education and
preparation, application of topical anesthetics) can be implemented ahead of time, either at home or upon arrival at the
vaccination setting, while the child is waiting to be vaccinated. Parents can be asked to pay a nominal fee to cover the
cost of analgesic interventions (e.g., topical anesthetics, bubble solution for blowing, sugar water). Alternatively, analgesic interventions can be provided free of charge.
To date, the guideline has been piloted in an outpatient
clinic setting and a public health vaccination setting at a middle school. Feedback received suggests that the strategies are
feasible and effective, and that parents and children appreciate efforts made to reduce the children’s pain.
Assessment and documentation of pain
Assessment and documentation of pain during vaccine injections are important aspects of providing quality care. These
processes allow determination of the effectiveness of analgesic
strategies employed and planning for future vaccine injections.
Adult observers (parents, health care providers or both)
can use validated pain assessment techniques to assess injection pain in preverbal children and infants. Verbal children
can be asked to self-report their pain using age-appropriate
techniques. Health care providers are encouraged to document the strategies used to reduce acute pain at the time of
vaccine injection, as well as the child’s pain score.
Clinical considerations
Some judgment about the suitability and feasibility of the recommendations is required, as not all of the recommendations
will be appropriate or effective in all situations or for all children. In selecting specific pain-relieving strategies for use in a
particular situation, clinicians and parents are advised to consider the analgesic effectiveness of individual modalities, the
goals for the child and the preferences of the child, the parents
and the clinician.
Health care providers should offer pain-relieving options
to parents and children (as appropriate) when they are counselling about other aspects of immunization or well-baby and
1994

child care, as parents and children are largely unaware of
effective pain-relieving strategies.
No single pain-relieving strategy recommended in this
guideline has been demonstrated to reliably reduce pain to
zero (i.e., to prevent pain). Clinicians are advised to combine
different pain-relieving strategies, as such combinations
improve pain relief.12 However, combining pain-relieving
strategies does not ensure pain-free injections.
Tools to support training and implementation
We developed a knowledge translation plan to facilitate dissemination and implementation of the guideline. This plan
incorporates several educational tools, including a guide to pain
management for parents and caregivers (Appendix 1, available
at www.cmaj.ca/cgi/content/full/cmaj.092048/DC1), a guide to
pain management for health care providers (Appendix 2, available at www.cmaj.ca/cgi/content/full/cmaj.092048/DC1), a tool
that health care providers can use to assess and document pain
(Appendix 3, available at www.cmaj.ca /cgi/content /full
/cmaj.092048/DC1) and a website and educational video for
parents and health care providers (available online and freely
accessible at www.sickkids.ca/Learning/SpotlightOnLearning
/profiles-in-learning/help-eliminate-pain-in-kids/index.html). In
addition, several professional organizations (listed at the end of
the article) have endorsed or supported this guideline and will
assist in its dissemination. This assistance includes online links
to the guideline and associated tools and incorporation of recommendations in immunization resources. Educational workshops are being offered to various stakeholder groups.
The guides for parents and health care providers are similar
and include information about pain-relieving strategies that are
relevant to each user group, as well as information about how
to implement them during vaccine injections. The documentation tool allows the health care provider to record information
about the vaccine or vaccines administered, the child’s age,
age-appropriate pain assessment techniques and the child’s
pain score. The form can be inserted into the child’s medical
chart and/or given to parents and caregivers. The educational
video demonstrates the use of pain-relieving strategies.

Limitations
The recommendations included in this guideline are limited
by the evidence that was available at the time of publication
of the three systematic reviews.10–12 Certain recommendations
have more research support than others. In addition, some of
the recommendations are applicable to children of all ages,
whereas others apply only to subgroups of children.
For some pain-relieving strategies (e.g., use of sweet-tasting
solutions, tactile stimulation), the optimal administration
technique and the upper and/or lower age limits for effectiveness could not be determined with confidence from the existing evidence.
Some of the research studies upon which the recommendations are based were limited in terms of the inclusion of children and parents with different demographic characteristics
and backgrounds. For instance, children with cognitive impairment or a history of traumatic needle procedures might not
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have been included. The guideline panel did not consider these
factors in the recommendations; however, we acknowledge
that the experience of pain may be mediated by such factors.
Moreover, they may influence the pain-relieving strategies that
clinicians, parents and children choose to employ.
Our literature search did not identify studies examining the
impact on injection-related pain of the environment or setting
in which vaccination was performed (e.g., clinic, school),
characteristics of the needle and selected aspects of the injection technique (e.g., gauge, length, angle of injection) or the
body region where the vaccine was injected (e.g., arm, thigh).
We recommend that future studies examine the effect of these
factors on pain at the time of vaccine injection.
For this guideline, we did not consider complementary and
alternative medicines, and the published effectiveness of such
therapies could be included in future revisions.

Directions for future research
At present, the optimal pain-relieving regimen for nullifying
pain, rather than simply diminishing pain, is unknown. Additional research is recommended to determine which painrelieving regimens reliably prevent pain in children of different ages. New technologies for administering vaccines (e.g.,
microneedles) and needle-free administration techniques
(e.g., nasal sprays) offer alternative ways of preventing pain
for which further investigation is also required.
The impact of consistent pain management during injection of vaccines on short-term and long-term outcomes,
including the child’s pain, satisfaction with the vaccination
experience, development of needle fears and adherence with
vaccination schedules, has not been evaluated. This is clearly
an important topic for future research.
The education of all primary stakeholders involved in
childhood immunization, including parents, children and
health care providers, is fundamental to any improvements in
the delivery of vaccine injections in children. Additional
research is planned to determine the impact of the knowledge
translation interventions for this guideline.
This article has been peer reviewed.
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